IMNM Collar Strategy
IMNM (Immunome, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Immunome, Inc., a biotechnology company, engages in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics in the United States. The company develops clinical asset comprising Varegacestat, a gamma secretase inhibitor that is in Phase 3 clinical trial for the treatment of desmoid tumors; and IM-1021, a receptor tyrosine kinase-like orphan receptor 1 antibody-drug conjugate (ADC), which is in Phase 1 clinical trial. It is also developing preclinical assets, including IM-3050, a fibroblast activation protein targeted radioligand therapy; and solid tumor ADC drug candidates, such as IM-1617, IM-1340, and IM-1335. Immunome, Inc. was incorporated in 2006 and is based in Bothell, Washington.
IMNM (Immunome, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $1.91B, a beta of 2.07 versus the broader market, a 52-week range of 7.96-27.65, average daily share volume of 1.3M, a public-listing history dating back to 2020, approximately 177 full-time employees. These structural characteristics shape how IMNM stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 2.07 indicates IMNM has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a collar on IMNM?
A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot.
Current IMNM snapshot
As of June 30, 2026, spot at $21.20, ATM IV 76.70%, IV rank 9.94%, expected move 21.99%. The collar on IMNM below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.
Why this collar structure on IMNM specifically: IV regime affects collar pricing on both sides; compressed IMNM IV at 76.70% typically pushes the short call premium to roughly offset the long put cost, with a market-implied 1-standard-deviation move of approximately 21.99% (roughly $4.66 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated IMNM expiries trade a higher absolute premium for lower per-day decay. Position sizing on IMNM should anchor to the underlying notional of $21.20 per share and to the trader's directional view on IMNM stock.
IMNM collar setup
The IMNM collar below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With IMNM near $21.20, the first option leg uses a $22.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed IMNM chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 IMNM shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $21.20 | long |
| Sell 1 | Call | $22.00 | $0.88 |
| Buy 1 | Put | $20.00 | $1.28 |
IMNM collar risk and reward
- Net Premium / Debit
- -$2,160.50
- Max Profit (per contract)
- $39.50
- Max Loss (per contract)
- -$160.50
- Breakeven(s)
- $21.61
- Risk / Reward Ratio
- 0.246
Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium.
IMNM collar payoff curve
Modeled P&L at expiration across a range of underlying prices for the collar on IMNM. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$160.50 |
| $4.70 | -77.8% | -$160.50 |
| $9.38 | -55.7% | -$160.50 |
| $14.07 | -33.6% | -$160.50 |
| $18.76 | -11.5% | -$160.50 |
| $23.44 | +10.6% | +$39.50 |
| $28.13 | +32.7% | +$39.50 |
| $32.81 | +54.8% | +$39.50 |
| $37.50 | +76.9% | +$39.50 |
| $42.19 | +99.0% | +$39.50 |
When traders use collar on IMNM
Collars on IMNM hedge an existing long IMNM stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
IMNM thesis for this collar
The market-implied 1-standard-deviation range for IMNM extends from approximately $16.54 on the downside to $25.86 on the upside. A IMNM collar hedges an existing long IMNM position with a protective put while financing the put cost via a short call; when the premiums roughly offset, the collar acts as a near-zero-cost insurance band around the current spot. Current IMNM IV rank near 9.94% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on IMNM at 76.70%. As a Healthcare name, IMNM options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to IMNM-specific events.
IMNM collar positions are structurally neutral (protective); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. IMNM positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move IMNM alongside the broader basket even when IMNM-specific fundamentals are unchanged. Always rebuild the position from current IMNM chain quotes before placing a trade.
Frequently asked questions
- What is a collar on IMNM?
- A collar on IMNM is the collar strategy applied to IMNM (stock). The strategy is structurally neutral (protective): A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot. With IMNM stock trading near $21.20, the strikes shown on this page are snapped to the nearest listed IMNM chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are IMNM collar max profit and max loss calculated?
- Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium. For the IMNM collar priced from the end-of-day chain at a 30-day expiry (ATM IV 76.70%), the computed maximum profit is $39.50 per contract and the computed maximum loss is -$160.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a IMNM collar?
- The breakeven for the IMNM collar priced on this page is roughly $21.61 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current IMNM market-implied 1-standard-deviation expected move is approximately 21.99%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a collar on IMNM?
- Collars on IMNM hedge an existing long IMNM stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
- How does current IMNM implied volatility affect this collar?
- IMNM ATM IV is at 76.70% with IV rank near 9.94%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.